Pulmonary arterial hypertension (PAH) is a major progressive form of pulmonary
hypertension (PH) with more than 4800 patients in the United States. In the last two …

Pulmonary hypertension (PH) because of chronic lung disease is categorized as Group 3
PH in the most recent classification system. Prevalence of these diseases is increasing over …

Background: Current classification of pulmonary hypertension (PH) is based on a relatively
simple combination of patient characteristics and hemodynamics. This limits customization …

Pulmonary arterial hypertension (PAH) is a vascular remodeling disease that pathologically
increases pulmonary vascular resistance. Ultimately, this leads to right ventricular failure …

Pulmonary hypertension in human patients can result from increased pulmonary vascular
tone, pressure transferred from the systemic circulation, dropout of small pulmonary vessels …

Pulmonary hypertension (PH) is a refractory and fatal disease characterized by excessive
pulmonary arterial cell remodeling. Uncontrolled proliferation and hypertrophy of pulmonary …

We have witnessed significant advances in the management of pulmonary arterial
hypertension (PAH)(1), a rare and severe condition characterized by intense pulmonary …

Pulmonary arterial hypertension (PAH) is a rare, life-threatening condition characterized by
dysregulated metabolism, pulmonary vascular remodeling, and loss of pulmonary vascular …

Pulmonary arterial hypertension is a chronic, progressive disorder of the pulmonary
vasculature with associated pulmonary and cardiac remodeling. PAH was a uniformly fatal …

Pulmonary arterial hypertension (PAH) is a rare and chronic lung disease characterized by
progressive occlusion of the small pulmonary arteries, which is associated with structural …